Improves access to lower-cost generic and biosimilar drugs.

File S4222 ("Improves access to lower-cost generic and biosimilar drugs.") is before the New Jersey Legislature and has not been decided. Latest step (May 14, 2026): Introduced in the Senate, Referred to Senate Commerce Committee.

New Jersey file S4222, before the New Jersey Legislature. Still to be decided as of 2026-05-14.

Read the official record for S4222

See everything up for a vote · This week in New Jersey · See what we have filed with the clerk